▲ ROKIT Genomics’ Booth at the Korean Society for Molecular and Cellular Biology (KSMCB) Conference

ROKIT Genomics, a precision omics analysis specialist and a subsidiary of ROKIT Healthcare, launched its latest 'Spatial Transcriptomics' analysis service while participating in the '2025 Korean Society for Molecular and Cellular Biology (KSMCB) Annual Meeting.' The conference was held at the International Convention Center Jeju (ICC Jeju) through October 2nd.

The KSMCB Annual Meeting is the largest academic event in Korea, gathering over 3,000 researchers from all life science sectors—including molecular biology, medicine, pharmacology, and agro-bioscience—to exchange the latest knowledge. At this conference, ROKIT Genomics unveiled its advanced spatial transcriptomics technology and officially launched the service, building upon its deep expertise and experience accumulated in the single-cell RNA sequencing (scRNA-seq) field.

Spatial transcriptomics is a next-generation technology that transcends conventional genomic analysis. It enables researchers to identify gene expression information in parallel with its precise positional context within a tissue. This allows researchers to visually confirm where specific genes are expressed, providing a more dimensional and accurate understanding of complex biological phenomena.

Notably, ROKIT Genomics has already demonstrated its technical expertise and commercial viability, generating significant revenue in the single-cell transcriptomics market. A key differentiator is its proven track record of successfully executing high-difficulty projects—such as analyzing challenging tissue samples or microenvironments—which showcases a distinct technological gap over competitors. Building on this unique know-how, the company is strategically positioned to naturally expand its business into the spatial transcriptomics service sector and lead the market.

This technology is highly anticipated to provide groundbreaking data and insights in various fields, including: ▲brain development research, ▲neurobiology, and ▲studies on the tumor microenvironment (TME) within cancer tissues.

A ROKIT Genomics spokesperson stated, “We were delighted to present ROKIT Genomics' advanced technology and analytical know-how to Korea's top researchers at this conference. We are confident that our spatial transcriptomics service, which combines morphological tissue information with transcriptomic data, will become an essential tool for overcoming the limitations of various life science studies.”

▲ Participation Announcement Poster for the Korean Society for Molecular and Cellular Biology (KSMCB) Conference